Figure 2 — Updated efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in elderly women with HR+/HER-2 metastatic or advanced breast cancer: patient-level network meta-analysis | Aging

Navigate

Submit an Article

Research Paper|Volume 17, Issue 5|pp. 1313–1327

Updated efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in elderly women with HR+/HER-2 metastatic or advanced breast cancer: patient-level network meta-analysis

Back to articleFigure 2(2 of 3)

100%

Figure 2.SUCRA plot of CDK 4/6 efficacy ranking for progression free survival vs. overall survival.